Literature DB >> 15446773

Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema.

Sabine A Fuchs1, Ronald H B Meyboom, Eugène P van Puijenbroek, Henk-Jan Guchelaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15446773     DOI： 10.1023/b:phar.0000035902.67235.5c

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN： 0928-1231


× No keyword cloud information.
  13 in total

1.  Are Angiotensin II Receptor Antagonists Safe in Patients With Previous Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema?

Authors:  Sabine A. Fuchs; Richard P. Koopmans; Henk-Jan Guchelaar; Carrie C. E. Brodie-Meijer; Ronald H. B. Meyboom
Journal:  Hypertension       Date:  2001-01       Impact factor: 10.190

2.  [Cross-sensitivity between angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonist].

Authors:  J P Touraud; E Collet; C Louguet; C Sgro; S Dalac; Y Dutronc; D Lambert
Journal:  Ann Dermatol Venereol       Date:  2002 Aug-Sep       Impact factor: 0.777

Review 3.  Angiotensin receptors and their therapeutic implications.

Authors:  K K Griendling; B Lassègue; R W Alexander
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

Review 4.  Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.

Authors:  K K Warner; J A Visconti; M M Tschampel
Journal:  Ann Pharmacother       Date:  2000-04       Impact factor: 3.154

5.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.

Authors:  P Gohlke; C Pees; T Unger
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

Review 7.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

8.  Angioedema associated with candesartan.

Authors:  Kang-Sha Lo
Journal:  Pharmacotherapy       Date:  2002-09       Impact factor: 4.705

9.  Angioneurotic edema attributed to the use of losartan.

Authors:  E W van Rijnsoever; W J Kwee-Zuiderwijk; J Feenstra
Journal:  Arch Intern Med       Date:  1998-10-12

Review 10.  Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?

Authors:  Laurence G Howes; Diane Tran
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228
View more
  3 in total

Review 1.  Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.

Authors:  Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong-Van den Berg; Paul E de Jong; Dick de Zeeuw; Lieven J P Annemans; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.

Authors:  Yunyu Huang; Qiyun Zhou; Flora M Haaijer-Ruskamp; Maarten J Postma
Journal:  BMC Nephrol       Date:  2014-01-15       Impact factor: 2.388

Review 3.  Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.

Authors:  Teresa Brown; Jimmy Gonzalez; Catherine Monteleone
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-10-10       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.